Tag: COVID

Government of China invests $1,24 million for the health of women and girls in Cyclone Idai affected districts of Zimbabwe

Healthtimes

THE Government of China and United Nations Population Fund (UNFPA) has donated  reproductive health medical equipment and medicines as part of the US$1,24 million support to the Government of Zimbabwe‘s Health Assistance Project for Women and Girls in Zimbabwe Affected by Tropical Cyclone Idai in Chimanimani and Chipinge districts. The objective of the health assistance project is to enable the Ministry of Health and Child Care (MoHCC) to strengthen emergency obstetric and neonatal care in the cyclone affected areas in Zimbabwe. This is in turn expected to contribute to the…

Read More

Compensation For COVAX Vaccine Recipients Who Develop Serious Reactions

Michael Gwarisa

THE World Health Organisation (WHO) has signed a no -fault compensation deal which will see  a lump-sum payment being made to recipients of the the COVAX vaccine who would have developed serious side effects and reaction getting paid for damages that would have occurred. By Michael Gwarisa The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for the administration of a no-fault compensation programme for the 92 low- and middle-income…

Read More

Vaccine Will Be Voluntary says Zim Government

Healthtimes

INFORMATION, Publicity and Broadcasting Services Minister, senator Monica Mutsvangwa says that the administration of the COVID-19 Vaccine will be voluntary and wont’ be forced on any citizen. By Staff Reporter Addressing a Post Cabinet Media Briefing, Senator Mutsvangwa said the it was imperative that the country accelerates the acquisition of vaccines in order to halt a potential third wave. Cabinet was informed that the country is saddled with a second wave of the COVID-19 pandemic that has manifested in high infection and death rates countrywide, with the compounding factor being…

Read More

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

Healthtimes

Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, with co-primary endpoints of 14 days…

Read More

Coronavirus Mutation Causing High False Negative Results In Zim-Lancet

Michael Gwarisa

NEW Coronavirus strains being reported worldwide could be the reason why most Laboratories in Zimbabwe have been recording high cases of false negative COVID-19 results of late, a top pathologist has said. By Michael Gwarisa Speaking during a virtual press briefing, Lancet Laboratories Chief Executive Officer, Dr Charlse Muronda said the viruses have changed their genetic makeup , in the process making it difficult for other  organisations which have not upgraded their testing equipment to pick the virus during testing procedures. One of the things that have happened with COVID-19…

Read More